The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike Nelson to lead Clinical Operations. Nelson, with 20+ years of industry experience, will play a vital role as he manages the overall clinical operations for Alexza’s clinical programs, including Phase I-IIb trials currently being conducted. Nelson joins a team of top engineers, scientists, and development experts who share a passion and drive to develop solutions for patients and physicians with unmet needs. The Chase Group’s thorough understanding of the executive recruiting process and vast network within the life sciences industry enabled them to guide Alexza and bring this search to completion by securing a candidate who brings the characteristics to excel within Alexza’s culture in addition to the technical expertise needed for this position. To learn more about collaborating with The Chase Group to secure high caliber talent for your leadership team, email karen@chasegroup.com
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike Nelson to lead Clinical Operations. Nelson, with 20+ years of industry experience, will play a vital role as he manages the overall clinical operations for Alexza’s clinical programs, including Phase I-IIb trials currently being conducted. Nelson joins a team of top engineers, scientists, and development experts who share a passion and drive to develop solutions for patients and physicians with unmet needs. The Chase Group’s thorough understanding of the executive recruiting process and vast network within the life sciences industry enabled them to guide Alexza and bring this search to completion by securing a candidate who brings the characteristics to excel within Alexza’s culture in addition to the technical expertise needed for this position. To learn more about collaborating with The Chase Group to secure high caliber talent for your leadership team, email karen@chasegroup.com- Categories: Biotechnology, Life Sciences
Ionis Director, Global HEOR, Rare Disease Immunology, Successfully Placed by The Chase Group
Ami Claxton, MS, PhD has joined Ionis Pharmaceuticals, Inc. as Director, Global HEOR Rare Disease Immunology. She will play a critical and significant role as…
Successful Placement at Avidity
The Chase Group is pleased to announce the successful completion of the Vice President, Medical Affairs search for Avidity Biosciences. Nathan Weedin brings 15+ years…
The Chase Group Successfully Completes Search for Amyloidosis Medical Affairs Leader
Ionis Pharmaceuticals has a 35-year track record of perfecting and advancing RNA-targeted drug discovery and development. Projecting a vast number of new transformational products on…
The Chase Group Identifies Chief Medical Officer for Arcturus Therapeutics
In late 2022, Arcturus Therapeutics retained The Chase Group to build out additions to the leadership team. Tasked with identifying the new Chief Medical Officer,…
The Chase Group Secures VP, Head of Regulatory Affairs, for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate…
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike…